{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:59:20Z","timestamp":1782442760891,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1038\/s41440-024-01878-2","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T09:04:01Z","timestamp":1725872641000},"page":"3304-3309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hypertension research 2024 update and perspectives: basic research"],"prefix":"10.1038","volume":"47","author":[{"given":"Kento","family":"Kitada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"key":"1878_CR1","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCRESAHA.123.322798","volume":"134","author":"B Coste","year":"2024","unstructured":"Coste B, Delmas P. PIEZO ion channels in cardiovascular functions and diseases. Circ Res. 2024;134:572\u201391.","journal-title":"Circ Res"},{"key":"1878_CR2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/HYPERTENSIONAHA.121.17972","volume":"79","author":"H Wang","year":"2022","unstructured":"Wang H, Yuan Z, Wang B, Li B, Lv H, He J, et al. COMP (cartilage oligomeric matrix protein), a novel Piezo1 regulator that controls blood pressure. Hypertension. 2022;79:549\u201361.","journal-title":"Hypertension"},{"key":"1878_CR3","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/HYPERTENSIONAHA.122.20767","volume":"80","author":"L Fei","year":"2023","unstructured":"Fei L, Xu M, Wang H, Zhong C, Jiang S, Lichtenberger FB, et al. Piezo1 mediates vasodilation induced by acute hyperglycemia in mouse renal arteries and microvessels. Hypertension. 2023;80:1598\u2013610.","journal-title":"Hypertension"},{"key":"1878_CR4","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1161\/CIRCRESAHA.122.320827","volume":"130","author":"OF Harraz","year":"2022","unstructured":"Harraz OF, Klug NR, Senatore AJ, Hill-Eubanks DC, Nelson MT. Piezo1 is a mechanosensor channel in central nervous system capillaries. Circ Res. 2022;130:1531\u201346.","journal-title":"Circ Res"},{"key":"1878_CR5","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/CIRCRESAHA.121.320565","volume":"131","author":"D Choi","year":"2022","unstructured":"Choi D, Park E, Yu RP, Cooper MN, Cho IT, Choi J, et al. Piezo1-regulated mechanotransduction controls flow-activated lymphatic expansion. Circ Res. 2022;131:e2\u2013e21.","journal-title":"Circ Res"},{"key":"1878_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI154611","volume":"132","author":"Y Hirata","year":"2022","unstructured":"Hirata Y, Nomura K, Kato D, Tachibana Y, Niikura T, Uchiyama K, et al. A Piezo1\/KLF15\/IL-6 axis mediates immobilization-induced muscle atrophy. J Clin Invest. 2022;132:1\u201313.","journal-title":"J Clin Invest"},{"key":"1878_CR7","doi-asserted-by":"crossref","first-page":"e141775","DOI":"10.1172\/JCI141775","volume":"132","author":"F Bartoli","year":"2022","unstructured":"Bartoli F, Debant M, Chuntharpursat-Bon E, Evans EL, Musialowski KE, Parsonage G, et al. Endothelial Piezo1 sustains muscle capillary density and contributes to physical activity. J Clin Invest. 2022;132:e141775.","journal-title":"J Clin Invest"},{"key":"1878_CR8","doi-asserted-by":"crossref","first-page":"e171468","DOI":"10.1172\/JCI171468","volume":"134","author":"MJ Matrongolo","year":"2023","unstructured":"Matrongolo MJ, Ang PS, Wu J, Jain A, Thackray JK, Reddy A, et al. Piezo1 agonist restores meningeal lymphatic vessels, drainage, and brain-CSF perfusion in craniosynostosis and aged mice. J Clin Invest. 2023;134:e171468.","journal-title":"J Clin Invest"},{"key":"1878_CR9","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174806","volume":"134","author":"R Carrisoza-Gaytan","year":"2024","unstructured":"Carrisoza-Gaytan R, Mutchler SM, Carattino F, Soong J, Dalghi MG, Wu P, et al. PIEZO1 is a distal nephron mechanosensor and is required for flow-induced K+ secretion. J Clin Invest. 2024;134:e174806.","journal-title":"J Clin Invest"},{"key":"1878_CR10","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.121.18750","volume":"79","author":"Y He","year":"2022","unstructured":"He Y, Deng B, Liu S, Luo S, Ning Y, Pan X, et al. Myeloid Piezo1 deletion protects renal fibrosis by restraining macrophage infiltration and activation. Hypertension. 2022;79:918\u201331.","journal-title":"Hypertension"},{"key":"1878_CR11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41440-023-01536-z","volume":"47","author":"S Ogino","year":"2024","unstructured":"Ogino S, Yoshikawa K, Nagase T, Mikami K, Nagase M. Roles of the mechanosensitive ion channel Piezo1 in the renal podocyte injury of experimental hypertensive nephropathy. Hypertens Res. 2024;47:747\u201359.","journal-title":"Hypertens Res"},{"key":"1878_CR12","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41440-023-01219-9","volume":"46","author":"K Ochiai","year":"2023","unstructured":"Ochiai K, Mochida Y, Nagase T, Fukuhara H, Yamaguchi Y, Nagase M. Upregulation of Piezo2 in the mesangial, renin, and perivascular mesenchymal cells of the kidney of Dahl salt-sensitive hypertensive rats and its reversal by esaxerenone. Hypertens Res. 2023;46:1234\u201346.","journal-title":"Hypertens Res"},{"key":"1878_CR13","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1161\/HYPERTENSIONAHA.124.21355","volume":"81","author":"DG Harrison","year":"2024","unstructured":"Harrison DG, Patrick DM. Immune mechanisms in hypertension. Hypertension. 2024;81:1659\u201374.","journal-title":"Hypertension"},{"key":"1878_CR14","volume":"13","author":"H Liang","year":"2022","unstructured":"Liang H, Liu B, Gao Y, Nie J, Feng S, Yu W, et al. Jmjd3\/IRF4 axis aggravates myeloid fibroblast activation and m2 macrophage to myofibroblast transition in renal fibrosis. Front Immunol. 2022;13:978262.","journal-title":"Front Immunol"},{"key":"1878_CR15","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1096\/fj.201902200RR","volume":"34","author":"M Huang","year":"2020","unstructured":"Huang M, Wang Q, Long F, Di Y, Wang J, Zhun Zhu Y, et al. Jmjd3 regulates inflammasome activation and aggravates DSS-induced colitis in mice. FASEB J. 2020;34:4107\u201319.","journal-title":"FASEB J"},{"key":"1878_CR16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1165\/rcmb.2015-0183OC","volume":"55","author":"C He","year":"2016","unstructured":"He C, Larson-Casey JL, Gu L, Ryan AJ, Murthy S, Carter AB. Cu,Zn-superoxide dismutase-mediated redox regulation of Jumonji domain containing 3 modulates macrophage polarization and pulmonary fibrosis. Am J Respir Cell Mol Biol. 2016;55:58\u201371.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1878_CR17","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1038\/s41440-023-01312-z","volume":"46","author":"Y Gao","year":"2023","unstructured":"Gao Y, Yu W, Song J, Nie J, Cui Z, Wen S, et al. JMJD3 ablation in myeloid cells confers renoprotection in mice with DOCA\/salt-induced hypertension. Hypertens Res. 2023;46:1934\u201348.","journal-title":"Hypertens Res"},{"key":"1878_CR18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1084\/jem.20171773","volume":"215","author":"AE Norlander","year":"2018","unstructured":"Norlander AE, Madhur MS, Harrison DG. The immunology of hypertension. J Exp Med. 2018;215:21\u201333.","journal-title":"J Exp Med"},{"key":"1878_CR19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature24628","volume":"551","author":"N Wilck","year":"2017","unstructured":"Wilck N, Matus MG, Kearney SM, Olesen SW, Forslund K, Bartolomaeus H, et al. Salt-responsive gut commensal modulates T(H)17 axis and disease. Nature. 2017;551:585\u20139.","journal-title":"Nature"},{"key":"1878_CR20","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1038\/s41440-023-01365-0","volume":"46","author":"JY Kim","year":"2023","unstructured":"Kim JY, Lee S, Jang S, Kim CW, Gu BH, Kim M, et al. T helper cell polarity determines salt sensitivity and hypertension development. Hypertens Res. 2023;46:2168\u201378.","journal-title":"Hypertens Res"},{"key":"1878_CR21","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJMoa2209900","volume":"387","author":"S Mailankody","year":"2022","unstructured":"Mailankody S, Devlin SM, Landa J, Nath K, Diamonte C, Carstens EJ, et al. GPRC5D-targeted CAR T cells for myeloma. N. Engl J Med. 2022;387:1196\u2013206.","journal-title":"N. Engl J Med"},{"key":"1878_CR22","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150807","volume":"132","author":"S Arcangeli","year":"2022","unstructured":"Arcangeli S, Bove C, Mezzanotte C, Camisa B, Falcone L, Manfredi F, et al. CAR T cell manufacturing from naive\/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome. J Clin Invest. 2022;132:e150807.","journal-title":"J Clin Invest"},{"key":"1878_CR23","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166028","volume":"133","author":"JE Jaspers","year":"2023","unstructured":"Jaspers JE, Khan JF, Godfrey WD, Lopez AV, Ciampricotti M, Rudin CM, et al. IL-18-secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models. J Clin Invest. 2023;133:e166028.","journal-title":"J Clin Invest"},{"key":"1878_CR24","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","volume":"28","author":"A Mackensen","year":"2022","unstructured":"Mackensen A, M\u00fcller F, Mougiakakos D, B\u00f6ltz S, Wilhelm A, Aigner M, et al. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nat Med. 2022;28:2124\u201332.","journal-title":"Nat Med"},{"key":"1878_CR25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","volume":"375","author":"JG Rurik","year":"2022","unstructured":"Rurik JG, Tomb\u00e1cz I, Yadegari A, M\u00e9ndez Fern\u00e1ndez PO, Shewale SV, Li L, et al. CAR T cells produced in vivo to treat cardiac injury. Science. 2022;375:91\u201396.","journal-title":"Science"},{"key":"1878_CR26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41586-023-06243-w","volume":"619","author":"DJ Baker","year":"2023","unstructured":"Baker DJ, Arany Z, Baur JA, Epstein JA, June CH. CAR T therapy beyond cancer: the evolution of a living drug. Nature. 2023;619:707\u201315.","journal-title":"Nature"},{"key":"1878_CR27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41440-021-00776-1","volume":"45","author":"K Tamura","year":"2022","unstructured":"Tamura K, Azushima K, Kinguchi S, Wakui H, Yamaji T. ATRAP, a receptor-interacting modulator of kidney physiology, as a novel player in blood pressure and beyond. Hypertens Res. 2022;45:32\u201339.","journal-title":"Hypertens Res"},{"key":"1878_CR28","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/CIRCRESAHA.122.319989","volume":"130","author":"KP Patel","year":"2022","unstructured":"Patel KP, Katsurada K, Zheng H. Cardiorenal syndrome: the role of neural connections between the heart and the kidneys. Circ Res. 2022;130:1601\u201317.","journal-title":"Circ Res"},{"key":"1878_CR29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41440-023-01480-y","volume":"47","author":"M Sotozawa","year":"2024","unstructured":"Sotozawa M, Kinguchi S, Wakui H, Azushima K, Funakoshi K, Nakajima W, et al. Enhancement of angiotensin II type 1 receptor-associated protein in the paraventricular nucleus suppresses angiotensin II-dependent hypertension. Hypertens Res. 2024;47:67\u201377.","journal-title":"Hypertens Res"},{"key":"1878_CR30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41440-023-01496-4","volume":"47","author":"S Taguchi","year":"2024","unstructured":"Taguchi S, Azushima K, Yamaji T, Suzuki T, Abe E, Tanaka S, et al. Angiotensin II type 1 receptor-associated protein deletion combined with angiotensin II stimulation accelerates the development of diabetic kidney disease in mice on a C57BL\/6 strain. Hypertens Res. 2024;47:55\u201366.","journal-title":"Hypertens Res"},{"key":"1878_CR31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/HYPERTENSIONAHA.122.20109","volume":"80","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Chu Y, Wang S, Tang J, Li H, Feng L, et al. Vascular smooth muscle TRPV4 (transient receptor potential vanilloid family member 4) channels regulate vasoconstriction and blood pressure in obesity. Hypertension. 2023;80:757\u201370.","journal-title":"Hypertension"},{"key":"1878_CR32","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/HYPERTENSIONAHA.123.21528","volume":"80","author":"RK Adapala","year":"2023","unstructured":"Adapala RK, Katari V, Kanugula AK, Ohanyan V, Paruchuri S, Thodeti CK. Deletion of endothelial TRPV4 protects heart from pressure overload-induced hypertrophy. Hypertension. 2023;80:2345\u201356.","journal-title":"Hypertension"},{"key":"1878_CR33","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1038\/s41440-023-01363-2","volume":"46","author":"X Wen","year":"2023","unstructured":"Wen X, Peng Y, Peng Y, Zhu Y, Yu F, Geng L, et al. Aortic smooth muscle TRPV4 channels regulate vasoconstriction in high salt-induced hypertension. Hypertens Res. 2023;46:2356\u201367.","journal-title":"Hypertens Res"},{"key":"1878_CR34","volume":"133","author":"X Hu","year":"2023","unstructured":"Hu X, Du L, Liu S, Lan Z, Zang K, Feng J, et al. A TRPV4-dependent neuroimmune axis in the spinal cord promotes neuropathic pain. J Clin Invest. 2023;133:e161507.","journal-title":"J Clin Invest"},{"key":"1878_CR35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152308","volume":"132","author":"E Avolio","year":"2022","unstructured":"Avolio E, Katare R, Thomas AC, Caporali A, Schwenke D, Carrabba M, et al. Cardiac pericyte reprogramming by MEK inhibition promotes arteriologenesis and angiogenesis of the ischemic heart. J Clin Invest. 2022;132:e152308.","journal-title":"J Clin Invest"},{"key":"1878_CR36","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162188","volume":"133","author":"P Quijada","year":"2023","unstructured":"Quijada P, Park S, Zhao P, Kolluri KS, Wong D, Shih KD, et al. Cardiac pericytes mediate the remodeling response to myocardial infarction. J Clin Invest. 2023;133:e162188.","journal-title":"J Clin Invest"},{"key":"1878_CR37","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1161\/CIRCULATIONAHA.123.064155","volume":"148","author":"L Alex","year":"2023","unstructured":"Alex L, Tuleta I, Hernandez SC, Hanna A, Venugopal H, Astorkia M, et al. Cardiac pericytes acquire a fibrogenic phenotype and contribute to vascular maturation after myocardial infarction. Circulation. 2023;148:882\u201398.","journal-title":"Circulation"},{"key":"1878_CR38","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2353\/ajpath.2008.080433","volume":"173","author":"SL Lin","year":"2008","unstructured":"Lin SL, Kisseleva T, Brenner DA, Duffield JS. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol. 2008;173:1617\u201327.","journal-title":"Am J Pathol"},{"key":"1878_CR39","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1172\/JCI72267","volume":"124","author":"JS Duffield","year":"2014","unstructured":"Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest. 2014;124:2299\u2013306.","journal-title":"J Clin Invest"},{"key":"1878_CR40","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1038\/s41440-023-01451-3","volume":"46","author":"H Ito","year":"2023","unstructured":"Ito H, Hirose T, Sato S, Takahashi C, Ishikawa R, Endo A, et al. Pericyte detachment and renal congestion involve interstitial injury and fibrosis in Dahl salt-sensitive rats and humans with heart failure. Hypertens Res. 2023;46:2705\u201317.","journal-title":"Hypertens Res"},{"key":"1878_CR41","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/s41440-023-01305-y","volume":"46","author":"S Dai","year":"2023","unstructured":"Dai S, Zhao L, Wang G, Chen C, Li C, Xiao B, et al. Celiac ganglia neurolysis suppresses high blood pressure in rats. Hypertens Res. 2023;46:1771\u201381.","journal-title":"Hypertens Res"},{"key":"1878_CR42","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s10147-022-02160-6","volume":"27","author":"K Kamata","year":"2022","unstructured":"Kamata K, Kinoshita M, Kinoshita I, Imai H, Ogura T, Matsumoto H, et al. Efficacy of EUS-guided celiac plexus neurolysis in combination with EUS-guided celiac ganglia neurolysis for pancreatic cancer-associated pain: a multicenter prospective trial. Int J Clin Oncol. 2022;27:1196\u2013201.","journal-title":"Int J Clin Oncol"},{"key":"1878_CR43","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s41581-023-00753-6","volume":"19","author":"EAB Azizan","year":"2023","unstructured":"Azizan EAB, Drake WM, Brown MJ. Primary aldosteronism: molecular medicine meets public health. Nat Rev Nephrol. 2023;19:788\u2013806.","journal-title":"Nat Rev Nephrol"},{"key":"1878_CR44","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1038\/s41440-023-01444-2","volume":"46","author":"X Wang","year":"2023","unstructured":"Wang X, Luo T, Yang Y, Zhou Y, Hou J, Wang P. Unilateral chemical ablation of the adrenal gland lowers blood pressure and alleviates target organ damage in spontaneously hypertensive rats. Hypertens Res. 2023;46:2693\u2013704.","journal-title":"Hypertens Res"},{"key":"1878_CR45","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0140-6736(23)02408-X","volume":"403","author":"KR Tuttle","year":"2024","unstructured":"Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, et al. Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial. Lancet. 2024;403:379\u201390.","journal-title":"Lancet"},{"key":"1878_CR46","volume":"132","author":"AL Huff","year":"2022","unstructured":"Huff AL, Jaffee EM, Zaidi N. Messenger RNA vaccines for cancer immunotherapy: progress promotes promise. J Clin Invest. 2022;132:e156211.","journal-title":"J Clin Invest"},{"key":"1878_CR47","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s41440-023-01302-1","volume":"46","author":"H Nakagami","year":"2023","unstructured":"Nakagami H. Challenges in the development of novel therapies, vaccines and siRNAs for the treatment of hypertension. Hypertens Res. 2023;46:1812\u20135.","journal-title":"Hypertens Res"},{"key":"1878_CR48","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.122.061516","volume":"147","author":"Z Ma","year":"2023","unstructured":"Ma Z, Mao C, Chen X, Yang S, Qiu Z, Yu B, et al. Peptide vaccine against ADAMTS-7 ameliorates atherosclerosis and postinjury neointima hyperplasia. Circulation. 2023;147:728\u201342.","journal-title":"Circulation"},{"key":"1878_CR49","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s41440-023-01265-3","volume":"46","author":"F Ke","year":"2023","unstructured":"Ke F, Kuang W, Hu X, Li C, Ma W, Shi D, et al. A novel vaccine targeting \u03b21-adrenergic receptor. Hypertens Res. 2023;46:1582\u201395.","journal-title":"Hypertens Res"},{"key":"1878_CR50","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41440-023-01466-w","volume":"47","author":"BA Jana","year":"2024","unstructured":"Jana BA, Shivhare P, Srivastava R. Gelatin-PVP dissolving microneedle-mediated therapy for controlled delivery of nifedipine for rapid antihypertension treatment. Hypertens Res. 2024;47:427\u201334.","journal-title":"Hypertens Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01878-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01878-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01878-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T10:23:38Z","timestamp":1733394218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01878-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1878"],"URL":"https:\/\/doi.org\/10.1038\/s41440-024-01878-2","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}